Clinical Trial Update: A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II study is evaluating regorafenib in combination with toripalimab and albumin-bound paclitaxel as third-line therapy for advanced pancreatic cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Stivarga (regorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Conditions: Pancreatic Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING